martes, 17 de octubre de 2023

Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00396-0/fulltext?dgcid=hubspot_update_feature_updatealerts_lanonc&utm_campaign=update-lanonc&utm_medium=email&_hsmi=278524532&_hsenc=p2ANqtz-9zFhztbiHatbqfVdZMLvixbFg4frY-iMvGtWYYVHEewC3-nHdA-n6wc-lSR7FIClZytFeh2ORnT9oBT2q1nFHDFmkZnQ&utm_content=278217911&utm_source=hs_email

No hay comentarios:

Publicar un comentario